/

Sociétés

AM

Sociétés

AMSBIOPHARMA

Ce que nous écrivons

Auto / AutomobilePharmacieSantéSanté PubliqueUniversité

33 communiqués de presse

Voir tous les communiqués de presse

Press Release cover image

11/03/2026

Musique

Santé

Santé Publique

CMC in the drug development process and IND analytical strategy | AMSbiopharma

Source

1.00

0

Press Release cover image

26/02/2026

Santé

Santé Publique

Gene and cell therapy analytical strategies and compliance | AMSbiopharma

Source

1.00

0

Press Release cover image

19/02/2026

Santé

Pharmacie

Santé Publique

EMA nitrosamines update and acceptable intake limits | AMSbiopharma

Source

1.00

0

Press Release cover image

05/02/2026

Santé

Santé Publique

Fit-for-purpose QC protocols for nucleic acid therapeutics | AMSbiopharma

Source

1.00

0

Press Release cover image

03/02/2026

Université

Santé

Santé Publique

How analytical CROs empower biotech innovation | AMSbiopharma

Source

1.00

0

Press Release cover image

18/12/2025

Santé

Santé Publique

UPLC-MS/MS method development for peptide analysis | AMSbiopharma

Source

1.00

0

Press Release cover image

11/12/2025

Santé

Santé Publique

Stability-indicating methods for peptide drug analysis | AMSbiopharma

Source

1.00

0

Press Release cover image

26/11/2025

Santé

Santé Publique

Accelerate Drug Development with Preclinical Contract Research | AMSbiopharma

Source

1.00

0

Press Release cover image

19/11/2025

Université

Santé

Santé Publique

Optimize LC‑MS/MS Sensitivity: Ion Suppression in Bioanalysis | AMSbiopharma

Source

1.00

0

Press Release cover image

29/10/2025

Santé

Santé Publique

Biomarkers for Bioanalytical Research in Drug Development | AMSbiopharma

Source

1.00

0

Followers

0

Compatibilité

0